Eagle Bay Advisors »

Allogene Therapeutics shares owned by Eagle Bay Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Eagle Bay Advisors from 13F filings

Historical chart of Eagle Bay Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Eagle Bay Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Eagle Bay Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $692 216 3.21
2023-09-30 $685 216 3.17
2023-06-30 $1.1k 216 4.97
2023-03-31 $533 108 4.94
2022-12-31 $678 108 6.29
2022-09-30 $1.0k 108 9.26
2022-06-30 $1.2k 108 11.40
2021-12-31 $2.0k 108 18.52
2021-09-30 $3.0k 108 27.78
2021-06-30 $3.0k 108 27.78